Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)

ClinicalTrials.gov ID: NCT07868835

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07868835. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 12:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 68-Week Efficacy and Safety Study of VK2735 Administered Orally for Weight Management in Participants Without Type 2 Diabetes Mellitus Who Are Obese, or Overweight With at Least One Weight-related Comorbid Condition

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is one of two planned Phase 3 studies to support the weight management indication for VK2735 Oral in obese (BMI ≥ 30 kg/m2) or overweight (BMI ≥ 27kg/m2) adults with at least one weight-related comorbidity without type 2 diabetes mellitus.

Study identification

NCT ID
NCT07868835
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Viking Therapeutics, Inc.
Industry
Enrollment
560 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2026 (Estimated)
Primary completion
Jul 2028 (Estimated)
Completion
Aug 2028 (Estimated)
Last update posted
Nov 16, 2026

2026 – 2028

United States locations

U.S. sites
20
U.S. states
17
U.S. cities
20
Facility City State ZIP Site status
Viking Clinical Site #1020 Tucson Arizona 85741 Recruiting
Viking Clinical Site #1018 Chula Vista California 91910 Recruiting
Viking Clinical Site #1015 Lake Forest California 92630 Recruiting
Viking Clinical Site #1005 Melbourne Florida 32934 Recruiting
Viking Clinical Site #1003 The Villages Florida 32162 Recruiting
Viking Clinical Site #1013 Atlanta Georgia 30329 Recruiting
Viking Clinical Site #1001 Evansville Indiana 47714 Recruiting
Viking Clinical Site #1009 Valparaiso Indiana 46383 Recruiting
Viking Clinical Site #1014 Louisville Kentucky 40213 Recruiting
Viking Clinical Site #1004 Richfield Minnesota 55423 Recruiting
Viking Clinical Site #1029 Jackson Mississippi 39206 Recruiting
Viking Clinical Site #1028 Springfield Missouri 65807 Recruiting
Viking Clinical Site #1006 Rochester New York 14609 Recruiting
Viking Clinical Site #1035 Morehead City North Carolina 28557 Recruiting
Viking Clinical Site #1023 Medford Oregon 97504 Recruiting
Viking Clinical Site #1002 East Greenwich Rhode Island 02818 Recruiting
Viking Clinical Site #1030 Henderson Tennessee 37075 Recruiting
Viking Clinical Site #1031 Abilene Texas 79606 Recruiting
Viking Clinical Site #1026 Salt Lake City Utah 84124 Recruiting
Viking Clinical Site #1011 Seattle Washington 98105 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07868835, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.